The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Miller Richard A Md since 2007.
This trader's CIK number is 1031847.
At the time of last reporting, Miller Richard A Md was the President and CEO of Corvus Pharmaceuticals, Inc.. (stock ticker symbol CRVS).
Also see all insider trading activities at Corvus Pharmaceuticals, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2007 | PCYC | 10,000 | $20,005 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | CRVS | 0 | $0 | 0 | $0 | 559,073 | $1,956,755 |
2024 | CRVS | 577,634 | $999,884 | 0 | $0 | 0 | $0 |
2022 | CRVS | 105,890 | $120,422 | 0 | $0 | 0 | $0 |
2021 | CRVS | 145,714 | $469,249 | 0 | $0 | 0 | $0 |
2019 | CRVS | 49,720 | $165,661 | 0 | $0 | 0 | $0 |
2018 | CRVS | 136,502 | $998,700 | 0 | $0 | 0 | $0 |
2017 | CRVS | 35,000 | $354,897 | 0 | $0 | 0 | $0 |
2. Corvus Pharmaceuticals, Inc. (CRVS)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2007-08-21 | PCYC | Buy | 5,000 | 2.00 | 10,005 |
2007-08-22 | PCYC | Buy | 5,000 | 2.00 | 10,000 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-05-07 | CRVS | Option Ex | 559,073 | 3.50 | 1,956,755 |
2024-05-06 | CRVS | Buy | 577,634 | 1.73 | 999,884 |
2022-09-28 | CRVS | Buy | 25,000 | .76 | 19,075 |
2022-09-20 | CRVS | Buy | 20,000 | .81 | 16,299 |
2022-06-24 | CRVS | Buy | 5,000 | 1.03 | 5,150 |
2022-06-27 | CRVS | Buy | 5,000 | 1.00 | 4,985 |
2022-06-06 | CRVS | Buy | 890 | 1.01 | 898 |
2022-06-02 | CRVS | Buy | 5,000 | .97 | 4,875 |
2022-03-31 | CRVS | Buy | 15,000 | 1.64 | 24,540 |
2022-03-15 | CRVS | Buy | 25,000 | 1.47 | 36,650 |
2022-03-17 | CRVS | Buy | 5,000 | 1.59 | 7,950 |
2021-08-20 | CRVS | Buy | 10,000 | 1.93 | 19,250 |
2021-05-04 | CRVS | Buy | 35,714 | 2.80 | 99,999 |
2021-02-17 | CRVS | Buy | 100,000 | 3.50 | 350,000 |
2019-11-12 | CRVS | Buy | 272 | 2.90 | 788 |
2019-11-13 | CRVS | Buy | 14,736 | 3.00 | 44,237 |
2019-08-06 | CRVS | Buy | 5,000 | 3.58 | 17,875 |
2019-08-07 | CRVS | Buy | 2,500 | 3.54 | 8,850 |
2019-06-13 | CRVS | Buy | 343 | 3.52 | 1,207 |
2019-06-14 | CRVS | Buy | 11,657 | 3.40 | 39,668 |
2019-06-07 | CRVS | Buy | 9,212 | 3.37 | 31,016 |
2019-06-11 | CRVS | Buy | 6,000 | 3.67 | 22,020 |
2018-12-27 | CRVS | Buy | 20,000 | 3.29 | 65,880 |
2018-12-20 | CRVS | Buy | 10,000 | 4.39 | 43,949 |
2018-12-06 | CRVS | Buy | 5,000 | 5.99 | 29,935 |
2018-12-04 | CRVS | Buy | 1,502 | 5.95 | 8,936 |
2018-03-12 | CRVS | Buy | 100,000 | 8.50 | 850,000 |
2017-11-20 | CRVS | Buy | 10,000 | 10.79 | 107,850 |
2017-06-09 | CRVS | Buy | 8,784 | 9.92 | 87,137 |
2017-06-12 | CRVS | Buy | 11,216 | 9.82 | 110,185 |
2017-06-13 | CRVS | Buy | 5,000 | 9.95 | 49,725 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Miller Richard A Md (President and CEO of Corvus Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.